Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Paracrine signaling is a form of cell-to-cell communication in which cells secrete bioactive molecules—such as growth factors, cytokines, chemokines, peptides, and small gaseous mediators—that diffuse over short distances to act on neighboring cells within the same tissue[1][2][6]. This localized mode of signal transmission allows rapid and spatially restricted cellular responses that are essential for processes such as development, tissue repair/wound healing, immune regulation, angiogenesis (formation of new blood vessels), synaptic transmission between neurons, and local inflammatory reactions[3][4][8]. Unlike endocrine signals that travel through the bloodstream to distant targets or autocrine signals that affect the secreting cell itself, paracrine signals are typically short-lived due to rapid degradation or uptake by nearby cells. Prominent examples include fibroblast growth factor (FGF), vascular endothelial growth factor (VEGF), transforming growth factor-beta family members (TGF-beta), nitric oxide in vasodilation pathways, neurotransmitters at synapses between nerve cells—and many others depending on context[1][6]. While individual components involved in paracrine signaling—such as receptors for FGF or VEGF—can be considered therapeutic targets with associated drugs and safety profiles ("receptor tyrosine kinases," "cytokine receptors," etc.), "paracrine signaling via secretion of bioactive molecules" describes an entire class/mechanism rather than a discrete molecular entity. Therefore it is not considered a canonical therapeutic target but rather an overarching biological concept/process.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Paracrine signaling (via secretion of bioactive molecules).